Woomera Therapeutics

Developing monoclonal antibody against multiple targets associated with the production and use of vasopressin in cancer.

placeLebanon, New Hampshire, United States calendar_todayFounded 2003 language woomeratherapeutics.com

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 202 times.

YearFilings
20132
20142
20152
20172
20181
20191
20221

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon